June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Retinal Targeted-Capture Next Generation Sequencing and CLIA Confirmation in a Representative Range of Patients with Inherited Retinal Degeneration
Author Affiliations & Notes
  • Sara J Bowne
    Human Genetics Center, Univ of Texas Health Science Cntr, Houston, TX
  • Lori S Sullivan
    Human Genetics Center, Univ of Texas Health Science Cntr, Houston, TX
  • Dianna K H Wheaton
    Retina Foundation of the Southwest, Dallas, TX
  • Kaylie Webb-Jones
    Retina Foundation of the Southwest, Dallas, TX
  • David G Birch
    Retina Foundation of the Southwest, Dallas, TX
  • Cheryl Avery
    Human Genetics Center, Univ of Texas Health Science Cntr, Houston, TX
  • Feng Wang
    HGSC, Dept. of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX
  • Rui Chen
    HGSC, Dept. of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX
  • Stephen P Daiger
    Human Genetics Center, Univ of Texas Health Science Cntr, Houston, TX
    Ruiz Dept. of Ophthalmology and Visual Science, University of Texas Health Science Cntr, Houston, TX
  • Footnotes
    Commercial Relationships Sara Bowne, None; Lori Sullivan, None; Dianna Wheaton, None; Kaylie Webb-Jones, None; David Birch, None; Cheryl Avery, None; Feng Wang, None; Rui Chen, None; Stephen Daiger, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 1241. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sara J Bowne, Lori S Sullivan, Dianna K H Wheaton, Kaylie Webb-Jones, David G Birch, Cheryl Avery, Feng Wang, Rui Chen, Stephen P Daiger; Retinal Targeted-Capture Next Generation Sequencing and CLIA Confirmation in a Representative Range of Patients with Inherited Retinal Degeneration. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):1241. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine the genetic cause of disease in a panel of clinically characterized retinal degeneration patients from Texas and surrounding states. This collection of genotype known, clinically-characterized patients will be a valuable resource for future clinical trials.

Methods: Patients with inherited retinal degeneration underwent complete ophthalmic exams and genetic consultations. Genomic DNA from each proband was analyzed for the presence of mutation in 163 retinal disease genes using a targeted-capture next-generation sequencing (NGS) research protocol. Di-deoxy sequencing validation of potential disease-causing variants was performed using CLIA protocols

Results: Forty-eight unrelated patients with a variety of retinal degenerations were tested. Twenty five (52%) had a diagnosis of retinitis pigmentosa (RP), ten (21%) had Leber’s congenital amaurosis, five (10%) had a form of cone dystrophy, three (6%) had Usher’s syndrome, and five (10%) had other rare forms of retinal degeneration. The majority of samples, 73%, were isolate in nature with no reported family history of retinal disease. Retinal targeted-capture NGS identified potentially pathogenic mutation(s) in 33 of the 48 patients tested. Pathogenicity analyses, including variant assessment and di-deoxy sequencing of probands and available family members, confirmed pathogenic or likely pathogenic mutations in 28 patients. Two additional patients were found to have variants of unknown significance in retinal disease associated genes. Pathogenic mutations were spread among 18 different genes.

Conclusions: Likely disease-causing mutations were identified in 58% of retinal degeneration patients. These genotype known patients are now an accessible, well characterized resource for enrollment in gene therapy and other clinical trials. This cohort of 48 patients is a pilot for “The Texas1000”, a project in development that aims to determine the genetic cause of retinal degeneration in 1,000 clinically characterized patients in Texas and nearby states.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×